Immune checkpoint inhibitors for progressive multifocal leukoencephalopathy

Saudi J Kidney Dis Transpl. 2019 Jul-Aug;30(4):998-999. doi: 10.4103/1319-2442.265483.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Antineoplastic Agents, Immunological / therapeutic use
  • Humans
  • Leukoencephalopathy, Progressive Multifocal / drug therapy*
  • Nivolumab / therapeutic use*

Substances

  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents, Immunological
  • Nivolumab
  • pembrolizumab